A Prescription for PAMA Reimbursement Cuts-The Facts and Strategies for Reducing Impact

As 2018 begins with clinical lab rates being reduced by PAMA legislation, we expect Medicare Part B reimbursement for lab testing to decline by approximately 10% this year. However, further rate reductions beyond 2018 are speculative at this time, as efforts to change and/or delay the law continue to escalate. Download this resource for more information on what hospitals should not do and what hospitals should do right now.